Denali Advisors’s ResMed RMD Stock Holding History

Denali Advisors’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-400	Closed	-$69K	–	429
2020 Q3	$69K	Sell	400 -200	-33%	-$36.9K	0.01%	286
2020 Q2	$115K	Buy	600 +400	+200%	+$65.4K	0.02%	284
2020 Q1	$29K	Sell	200 -400	-67%	-$63.7K	0.01%	308
2019 Q4	$93K	Sell	600 -2,300	-79%	-$331K	0.01%	264
2019 Q3	$392K	Hold	2,900	–	–	0.05%	194
2019 Q2	$354K	Sell	2,900 -61,600	-96%	-$6.82M	0.05%	164
2019 Q1	$6.71M	Sell	64,500 -59,000	-48%	-$6.09M	1.07%	40
2018 Q4	$14.1M	Sell	123,500 -2,000	-2%	-$214K	2.35%	9
2018 Q3	$14.5M	Buy	125,500 +116,400	+1,279%	+$12.8M	2.13%	15
2018 Q2	$943K	Buy	+9,100	New	+$921K	0.14%	86
2016 Q4	–	Sell	-11,000	Closed	-$713K	–	306
2016 Q3	$713K	Sell	11,000 -7,800	-41%	-$519K	0.11%	107
2016 Q2	$1.19M	Buy	18,800 +18,200	+3,033%	+$1.07M	0.2%	93
2016 Q1	$35K	Buy	+600	New	+$34K	0.01%	133

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Denali Advisors's RMD Position: Q4 2020 in Review

Denali Advisors sold out of ResMed (RMD) in Q4 2020, closing a stake of 400 shares — an estimated $69K sold.

Denali Advisors first reported a position in RMD in Q1 2016 and held it in 13 quarters. The position peaked at $14.5M in Q3 2018. 663 funds tracked by Wall St. Rank hold RMD as of Q4 2020.

Denali Advisors reported no remaining ResMed position as of Q4 2020 after selling out during the quarter.
Denali Advisors sold 400 ResMed shares in Q4 2020, an estimated $69K.
Denali Advisors first reported a position in ResMed in Q1 2016 and held it in 13 quarters.
Denali Advisors's ResMed position peaked at $14.5M in Q3 2018.
663 funds tracked by Wall St. Rank held ResMed as of Q4 2020.

Based on Denali Advisors's 13F filing for Q4 2020, filed 20 Jan 2021.